News | 16 January 2013
In 2010, China's State Food and Drug Administration (?SFDA?) issued a new version of its Good Manufacturing Practice (the ?GMP?) regulations, which require manufacturers of sterile drugs (including blood products, vaccines, injections, etc.) to receive ...
Click on the link to read the full article at Lexology (registration)
(This link will open in a new window)